{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T20:08:59Z","timestamp":1790712539207,"version":"4.1.0"},"reference-count":104,"publisher":"Elsevier","isbn-type":[{"value":"9780444642080","type":"print"}],"license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100009104","name":"Universit\u00e0 Degli Studi di Modena e Reggio Emila","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009104","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019]]},"DOI":"10.1016\/bs.pbr.2019.03.001","type":"book-chapter","created":{"date-parts":[[2019,4,2]],"date-time":"2019-04-02T18:46:41Z","timestamp":1554230801000},"page":"57-88","source":"Crossref","is-referenced-by-count":47,"title":["Nanomedicine in Alzheimer's disease: Amyloid beta targeting strategy"],"prefix":"10.1016","author":[{"given":"Giovanni","family":"Tosi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Pederzoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Belletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Angela","family":"Vandelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavio","family":"Forni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason Thomas","family":"Duskey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Ruozi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/bs.pbr.2019.03.001_bb0010","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jconrel.2014.04.010","article-title":"Engineering theranostic nanovehicles capable of targeting cerebrovascular amyloid deposits","volume":"185","author":"Agyare","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/bs.pbr.2019.03.001_bb0015","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s11671-008-9178-5","article-title":"Gold nanoparticles and microwave irradiation inhibit Beta-amyloid Amyloidogenesis","volume":"3","author":"Araya","year":"2008","journal-title":"Nanoscale Res. Lett."},{"key":"10.1016\/bs.pbr.2019.03.001_bb0020","doi-asserted-by":"crossref","first-page":"14022","DOI":"10.1523\/JNEUROSCI.0284-14.2014","article-title":"Multifunctional liposomes reduce brain beta-amyloid burden and ameliorate memory impairment in Alzheimer's disease mouse models","volume":"34","author":"Balducci","year":"2014","journal-title":"J. Neurosci."},{"key":"10.1016\/bs.pbr.2019.03.001_bb0025","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1016\/j.nano.2013.12.001","article-title":"Liposomes bi-functionalized with phosphatidic acid and an ApoE-derived peptide affect Abeta aggregation features and cross the blood-brain-barrier: implications for therapy of Alzheimer disease","volume":"10","author":"Bana","year":"2014","journal-title":"Nanomedicine"},{"key":"10.1016\/bs.pbr.2019.03.001_bb0030","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1007\/s00702-013-0992-2","article-title":"Interaction of selegiline-loaded PLGA-b-PEG nanoparticles with beta-amyloid fibrils","volume":"120","author":"Baysal","year":"2013","journal-title":"J. Neural Transm. (Vienna)"},{"key":"10.1016\/bs.pbr.2019.03.001_bb0035","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s00702-016-1527-4","article-title":"Donepezil loaded PLGA-b-PEG nanoparticles: their ability to induce destabilization of amyloid fibrils and to cross blood brain barrier in vitro","volume":"124","author":"Baysal","year":"2017","journal-title":"J. Neural Transm. (Vienna)"},{"key":"10.1016\/bs.pbr.2019.03.001_bb0040","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.nano.2011.05.009","article-title":"Liposomes functionalized with acidic lipids rescue Abeta-induced toxicity in murine neuroblastoma cells","volume":"7","author":"Bereczki","year":"2011","journal-title":"Nanomedicine"},{"key":"10.1016\/bs.pbr.2019.03.001_bb0045","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s00401-010-0719-5","article-title":"Neuropathology after active Abeta42 immunotherapy: implications for Alzheimer's disease pathogenesis","volume":"120","author":"Boche","year":"2010","journal-title":"Acta Neuropathol."},{"key":"10.1016\/bs.pbr.2019.03.001_bb0050","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.nano.2011.03.008","article-title":"Nanotechnologies for Alzheimer's disease: diagnosis, therapy, and safety issues","volume":"7","author":"Brambilla","year":"2011","journal-title":"Nanomedicine"},{"key":"10.1016\/bs.pbr.2019.03.001_bb0055","doi-asserted-by":"crossref","first-page":"5897","DOI":"10.1021\/nn300489k","article-title":"PEGylated nanoparticles bind to and Alter amyloid-Beta peptide conformation: toward engineering of functional Nanomedicines for Alzheimer's disease","volume":"6","author":"Brambilla","year":"2012","journal-title":"ACS Nano"},{"key":"10.1016\/bs.pbr.2019.03.001_bb0060","doi-asserted-by":"crossref","first-page":"15437","DOI":"10.1021\/ja8041806","article-title":"Inhibition of amyloid beta protein fibrillation by polymeric nanoparticles","volume":"130","author":"Cabaleiro-Lago","year":"2008","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/bs.pbr.2019.03.001_bb0065","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.nano.2017.12.006","article-title":"Antibody-functionalized polymer nanoparticle leading to memory recovery in Alzheimer's disease-like transgenic mouse model","volume":"14","author":"Carradori","year":"2018","journal-title":"Nanomedicine"},{"key":"10.1016\/bs.pbr.2019.03.001_bb0070","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1002\/cbic.200700338","article-title":"Branched KLVFF tetramers strongly potentiate inhibition of beta-amyloid aggregation","volume":"8","author":"Chafekar","year":"2007","journal-title":"Chembiochem"},{"key":"10.1016\/bs.pbr.2019.03.001_bb0075","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1208\/s12248-012-9444-4","article-title":"Highly stabilized curcumin nanoparticles tested in an in vitro blood-brain barrier model and in Alzheimer's disease Tg2576 mice","volume":"15","author":"Cheng","year":"2013","journal-title":"AAPS J."},{"key":"10.1016\/bs.pbr.2019.03.001_bb0080","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.neuint.2017.02.012","article-title":"Multifunctional liposomes interact with Abeta in human biological fluids: therapeutic implications for Alzheimer's disease","volume":"108","author":"Conti","year":"2017","journal-title":"Neurochem. Int."},{"key":"10.1016\/bs.pbr.2019.03.001_bb0085","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3233\/JAD-2012-111139","article-title":"Therapeutic albumin binding to remove amyloid-beta","volume":"29","author":"Costa","year":"2012","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/bs.pbr.2019.03.001_bb0090","doi-asserted-by":"crossref","first-page":"8850","DOI":"10.1073\/pnas.151261398","article-title":"Peripheral anti-A\u03b2 antibody alters CNS and plasma A\u03b2 clearance and decreases brain A\u03b2 burden in a mouse model of Alzheimer's disease","volume":"98","author":"DeMattos","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/bs.pbr.2019.03.001_bb0095","doi-asserted-by":"crossref","first-page":"115","DOI":"10.2174\/156802607779318262","article-title":"Disrupting beta-amyloid aggregation for Alzheimer disease treatment","volume":"7","author":"Estrada","year":"2007","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/bs.pbr.2019.03.001_bb0100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0082331","article-title":"Pharmacokinetics, brain delivery, and efficacy in brain tumor-bearing mice of glutathione pegylated liposomal doxorubicin (2B3-101)","volume":"9","author":"Gaillard","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/bs.pbr.2019.03.001_bb0105","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1021\/bm401906p","article-title":"RVG-peptide-linked trimethylated chitosan for delivery of siRNA to the brain","volume":"15","author":"Gao","year":"2014","journal-title":"Biomacromolecules"},{"key":"10.1016\/bs.pbr.2019.03.001_bb0110","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1002\/mabi.200400189","article-title":"Conformational changes of the amyloid beta-peptide (1-40) adsorbed on solid surfaces","volume":"5","author":"Giacomelli","year":"2005","journal-title":"Macromol. Biosci."},{"key":"10.1016\/bs.pbr.2019.03.001_bb0115","doi-asserted-by":"crossref","first-page":"245","DOI":"10.3389\/fnins.2015.00245","article-title":"Barriers to developing a valid rodent model of Alzheimer's disease: from behavioral analysis to etiological mechanisms","volume":"9","author":"Gidyk","year":"2015","journal-title":"Front. Neurosci."},{"key":"10.1016\/bs.pbr.2019.03.001_bb0120","doi-asserted-by":"crossref","first-page":"10582","DOI":"10.1523\/JNEUROSCI.1736-09.2009","article-title":"Beta-amyloid monomers are neuroprotective","volume":"29","author":"Giuffrida","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/bs.pbr.2019.03.001_bb0125","doi-asserted-by":"crossref","first-page":"6519","DOI":"10.1016\/j.biomaterials.2010.04.044","article-title":"Lipid-based nanoparticles with high binding affinity for amyloid-beta1-42 peptide","volume":"31","author":"Gobbi","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/bs.pbr.2019.03.001_bb0130","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0002-9440(10)64700-1","article-title":"Intraneuronal A\u03b242 accumulation in human brain","volume":"156","author":"Gouras","year":"2000","journal-title":"Am. J. Pathol."},{"key":"10.1016\/bs.pbr.2019.03.001_bb0135","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.2217\/nnm.14.206","article-title":"Nanomedicine for the treatment of Alzheimer's disease","volume":"10","author":"Gregori","year":"2015","journal-title":"Nanomedicine (Lond.)"},{"key":"10.1016\/bs.pbr.2019.03.001_bb0140","doi-asserted-by":"crossref","first-page":"897","DOI":"10.2217\/nnm.10.74","article-title":"Improving the brain delivery of gold nanoparticles by conjugation with an amphipathic peptide","volume":"5","author":"Guerrero","year":"2010","journal-title":"Nanomedicine (Lond.)"},{"key":"10.1016\/bs.pbr.2019.03.001_bb0145","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1021\/bc200362a","article-title":"Synthesis and in vivo evaluation of the biodistribution of a 18F-labeled conjugate gold-nanoparticle-peptide with potential biomedical application","volume":"23","author":"Guerrero","year":"2012","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/bs.pbr.2019.03.001_bb0150","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.plipres.2010.09.001","article-title":"Apolipoprotein E: from lipid transport to neurobiology","volume":"50","author":"Hauser","year":"2011","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/bs.pbr.2019.03.001_bb0155","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1006\/jcis.1994.1182","article-title":"Structural and electrostatic properties of globular proteins at a polystyrene-water Interface","volume":"164","author":"Haynes","year":"1994","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/bs.pbr.2019.03.001_bb0160","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.2217\/nnm-2016-0019","article-title":"Advances in nanomedicine for the treatment of Alzheimer's and Parkinson's diseases","volume":"11","author":"Hernando","year":"2016","journal-title":"Nanomedicine (Lond.)"},{"key":"10.1016\/bs.pbr.2019.03.001_bb0165","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1038\/srep01472","article-title":"Global brain delivery of neprilysin gene by intravascular administration of AAV vector in mice","volume":"3","author":"Iwata","year":"2013","journal-title":"Sci. Rep."},{"key":"10.1016\/bs.pbr.2019.03.001_bb0170","doi-asserted-by":"crossref","first-page":"8754","DOI":"10.1073\/pnas.0710823105","article-title":"Enhanced clearance of Abeta in brain by sustaining the plasmin proteolysis cascade","volume":"105","author":"Jacobsen","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/bs.pbr.2019.03.001_bb0175","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.nano.2011.06.008","article-title":"Chitosan enhances the stability and targeting of immuno-nanovehicles to cerebro-vascular deposits of Alzheimer's disease amyloid protein","volume":"8","author":"Jaruszewski","year":"2012","journal-title":"Nanomedicine"},{"key":"10.1016\/bs.pbr.2019.03.001_bb0180","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1016\/j.biomaterials.2013.10.075","article-title":"Multimodal nanoprobes to target cerebrovascular amyloid in Alzheimer's disease brain","volume":"35","author":"Jaruszewski","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/bs.pbr.2019.03.001_bb0185","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0014-4886(03)00268-1","article-title":"The p38 MAP kinase signaling pathway in Alzheimer's disease","volume":"183","author":"Johnson","year":"2003","journal-title":"Exp. Neurol."},{"key":"10.1016\/bs.pbr.2019.03.001_bb0190","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0010549","article-title":"Antibodies targeted to the brain with image-guided focused ultrasound reduces amyloid-beta plaque load in the TgCRND8 mouse model of Alzheimer's disease","volume":"5","author":"Jordao","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/bs.pbr.2019.03.001_bb0195","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/nrd3505","article-title":"The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics","volume":"10","author":"Karran","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/bs.pbr.2019.03.001_bb0200","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/S0006-291X(03)00393-0","article-title":"Fullerene inhibits beta-amyloid peptide aggregation","volume":"303","author":"Kim","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/bs.pbr.2019.03.001_bb0205","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1021\/nl0516862","article-title":"Nanoparticle-mediated local and remote manipulation of protein aggregation","volume":"6","author":"Kogan","year":"2006","journal-title":"Nano Lett."},{"key":"10.1016\/bs.pbr.2019.03.001_bb0210","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.pnpbp.2010.07.018","article-title":"Novel insights for the treatment of Alzheimer's disease","volume":"35","author":"Kurz","year":"2011","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/bs.pbr.2019.03.001_bb0215","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.nano.2012.11.004","article-title":"Curcumin-conjugated nanoliposomes with high affinity for Abeta deposits: possible applications to Alzheimer disease","volume":"9","author":"Lazar","year":"2013","journal-title":"Nanomedicine"},{"key":"10.1016\/bs.pbr.2019.03.001_bb0220","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1002\/pro.5560020312","article-title":"Thioflavine T interaction with synthetic Alzheimer's disease beta-amyloid peptides: detection of amyloid aggregation in solution","volume":"2","author":"LeVine","year":"1993","journal-title":"Protein Sci."},{"key":"10.1016\/bs.pbr.2019.03.001_bb0225","doi-asserted-by":"crossref","first-page":"3631","DOI":"10.1002\/smll.201201068","article-title":"Negatively charged gold nanoparticles inhibit Alzheimer's amyloid-beta fibrillization, induce fibril dissociation, and mitigate neurotoxicity","volume":"8","author":"Liao","year":"2012","journal-title":"Small"},{"key":"10.1016\/bs.pbr.2019.03.001_bb0230","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.jconrel.2016.06.001","article-title":"Messenger RNA-based therapeutics for brain diseases: an animal study for augmenting clearance of beta-amyloid by intracerebral administration of neprilysin mRNA loaded in polyplex nanomicelles","volume":"235","author":"Lin","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/bs.pbr.2019.03.001_bb0235","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.nbd.2005.01.022","article-title":"A novel peptide defined through phage display for therapeutic protein and vector neuronal targeting","volume":"19","author":"Liu","year":"2005","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/bs.pbr.2019.03.001_bb0240","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.brainres.2012.10.039","article-title":"Investigation of the performance of PEG-PEI\/ROCK-II-siRNA complexes for Alzheimer's disease in vitro","volume":"1490","author":"Liu","year":"2013","journal-title":"Brain Res."},{"key":"10.1016\/bs.pbr.2019.03.001_bb0245","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.colsurfb.2015.06.067","article-title":"Dual ligand immunoliposomes for drug delivery to the brain","volume":"134","author":"Loureiro","year":"2015","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/bs.pbr.2019.03.001_bb0250","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.colsurfb.2016.04.041","article-title":"Cellular uptake of PLGA nanoparticles targeted with anti-amyloid and anti-transferrin receptor antibodies for Alzheimer's disease treatment","volume":"145","author":"Loureiro","year":"2016","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/bs.pbr.2019.03.001_bb0255","series-title":"High Density Lipoprotein Structure\u2013Function and Role in Reverse Cholesterol Transport","author":"Lund-Katz","year":"2010"},{"key":"10.1016\/bs.pbr.2019.03.001_bb0260","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.nano.2015.09.003","article-title":"The hunt for brain Abeta oligomers by peripherally circulating multi-functional nanoparticles: potential therapeutic approach for Alzheimer disease","volume":"12","author":"Mancini","year":"2016","journal-title":"Nanomedicine"},{"key":"10.1016\/bs.pbr.2019.03.001_bb0265","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.ejpb.2010.11.015","article-title":"Uptake and permeability studies of BBB-targeting immunoliposomes using the hCMEC\/D3 cell line","volume":"77","author":"Markoutsa","year":"2011","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/bs.pbr.2019.03.001_bb0270","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ejpb.2012.02.006","article-title":"Anti-Abeta-MAb and dually decorated nanoliposomes: effect of Abeta1-42 peptides on interaction with hCMEC\/D3 cells","volume":"81","author":"Markoutsa","year":"2012","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/bs.pbr.2019.03.001_bb0275","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1046\/j.1471-4159.1997.69051995.x","article-title":"Isoform-specific effects of apolipoproteins E2, E3, and E4 on cerebral capillary sequestration and blood-brain barrier transport of circulating Alzheimer's amyloid beta","volume":"69","author":"Martel","year":"1997","journal-title":"J. Neurochem."},{"key":"10.1016\/bs.pbr.2019.03.001_bb0280","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0032616","article-title":"Curcumin loaded-PLGA nanoparticles conjugated with Tet-1 peptide for potential use in Alzheimer's disease","volume":"7","author":"Mathew","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/bs.pbr.2019.03.001_bb0285","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1523\/JNEUROSCI.23-01-00029.2003","article-title":"Novel therapeutic approach for the treatment of Alzheimer's disease by peripheral administration of agents with an affinity to beta-amyloid","volume":"23","author":"Matsuoka","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/bs.pbr.2019.03.001_bb0290","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.jconrel.2010.11.013","article-title":"Development and evaluation of polymer nanoparticles for oral delivery of estradiol to rat brain in a model of Alzheimer's pathology","volume":"150","author":"Mittal","year":"2011","journal-title":"J. Control. Release"},{"key":"10.1016\/bs.pbr.2019.03.001_bb0295","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ejmech.2014.04.050","article-title":"Multifunctional nanoliposomes with curcumin-lipid derivative and brain targeting functionality with potential applications for Alzheimer disease","volume":"80","author":"Mourtas","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/bs.pbr.2019.03.001_bb0300","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1021\/mp900306x","article-title":"ApoE3 mediated poly(butyl) cyanoacrylate nanoparticles containing curcumin: study of enhanced activity of curcumin against beta amyloid induced cytotoxicity using in vitro cell culture model","volume":"7","author":"Mulik","year":"2010","journal-title":"Mol. Pharm."},{"key":"10.1016\/bs.pbr.2019.03.001_bb0305","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.bbrc.2011.09.097","article-title":"Key residues for the oligomerization of Abeta42 protein in Alzheimer's disease","volume":"414","author":"Ngo","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/bs.pbr.2019.03.001_bb0310","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jconrel.2011.02.028","article-title":"Dual-targeted polyplexes: one step towards a synthetic virus for cancer gene therapy","volume":"152","author":"Nie","year":"2011","journal-title":"J. Control. Release"},{"key":"10.1016\/bs.pbr.2019.03.001_bb0315","doi-asserted-by":"crossref","first-page":"184","DOI":"10.2353\/ajpath.2006.050593","article-title":"A dynamic relationship between intracellular and extracellular pools of A\u03b2","volume":"168","author":"Oddo","year":"2006","journal-title":"Am. J. Pathol."},{"key":"10.1016\/bs.pbr.2019.03.001_bb0320","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.nano.2014.09.015","article-title":"Repeated intraperitoneal injections of liposomes containing phosphatidic acid and cardiolipin reduce amyloid-beta levels in APP\/PS1 transgenic mice","volume":"11","author":"Ordonez-Gutierrez","year":"2015","journal-title":"Nanomedicine"},{"key":"10.1016\/bs.pbr.2019.03.001_bb0325","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.ejps.2017.03.010","article-title":"Multifunctional LUV liposomes decorated for BBB and amyloid targeting\u2014B. In vivo brain targeting potential in wild-type and APP\/PS1 mice","volume":"102","author":"Papadia","year":"2017","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/bs.pbr.2019.03.001_bb0330","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.ejps.2017.02.019","article-title":"Multifunctional LUV liposomes decorated for BBB and amyloid targeting. A. In vitro proof-of-concept","volume":"101","author":"Papadia","year":"2017","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/bs.pbr.2019.03.001_bb0335","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1002\/jgm.1062","article-title":"Neuron-specific delivery of nucleic acids mediated by Tet1-modified poly(ethylenimine)","volume":"9","author":"Park","year":"2007","journal-title":"J. Gene Med."},{"key":"10.1016\/bs.pbr.2019.03.001_bb0340","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/j.1471-4159.2007.04591.x","article-title":"In vivo targeting of antibody fragments to the nervous system for Alzheimer's disease immunotherapy and molecular imaging of amyloid plaques","volume":"102","author":"Poduslo","year":"2007","journal-title":"J. Neurochem."},{"key":"10.1016\/bs.pbr.2019.03.001_bb0345","doi-asserted-by":"crossref","first-page":"7194","DOI":"10.1016\/j.biomaterials.2012.06.063","article-title":"Delivery of gold nanoparticles to the brain by conjugation with a peptide that recognizes the transferrin receptor","volume":"33","author":"Prades","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/bs.pbr.2019.03.001_bb0350","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.jbiotec.2011.06.037","article-title":"Functionalization with ApoE-derived peptides enhances the interaction with brain capillary endothelial cells of nanoliposomes binding amyloid-beta peptide","volume":"156","author":"Re","year":"2011","journal-title":"J. Biotechnol."},{"key":"10.1016\/bs.pbr.2019.03.001_bb0355","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.nano.2011.05.004","article-title":"Functionalization of liposomes with ApoE-derived peptides at different density affects cellular uptake and drug transport across a blood-brain barrier model","volume":"7","author":"Re","year":"2011","journal-title":"Nanomedicine"},{"key":"10.1016\/bs.pbr.2019.03.001_bb0360","doi-asserted-by":"crossref","first-page":"332","DOI":"10.3934\/molsci.2015.3.332","article-title":"Drugs and drug delivery systems targeting amyloid-\u03b2 in Alzheimer's disease","volume":"2","author":"Robinson","year":"2015","journal-title":"AIMS Mol. Sci."},{"key":"10.1016\/bs.pbr.2019.03.001_bb0365","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1002\/cphc.200500158","article-title":"Adsorption of amyloid beta-peptide at polymer surfaces: a neutron reflectivity study","volume":"6","author":"Rocha","year":"2005","journal-title":"Chemphyschem"},{"key":"10.1016\/bs.pbr.2019.03.001_bb0370","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jconrel.2015.02.012","article-title":"Enhanced glutathione PEGylated liposomal brain delivery of an anti-amyloid single domain antibody fragment in a mouse model for Alzheimer's disease","volume":"203","author":"Rotman","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/bs.pbr.2019.03.001_bb0375","doi-asserted-by":"crossref","first-page":"4169","DOI":"10.2174\/0929867321666140716100056","article-title":"Nanotechnology and Alzheimer's disease: what has been done and what to do","volume":"21","author":"Ruozi","year":"2014","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/bs.pbr.2019.03.001_bb0380","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.2174\/1871527315666160915112210","article-title":"Potential use of Nanomedicine for drug delivery across the blood-brain barrier in healthy and diseased brain","volume":"15","author":"Ruozi","year":"2016","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1016\/bs.pbr.2019.03.001_bb0385","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.ijpharm.2017.05.015","article-title":"Novel Curcumin loaded nanoparticles engineered for blood-brain barrier crossing and able to disrupt Abeta aggregates","volume":"526","author":"Ruozi","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/bs.pbr.2019.03.001_bb0390","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1016\/j.neurobiolaging.2009.11.012","article-title":"Differential recognition of vascular and parenchymal beta amyloid deposition","volume":"32","author":"Rutgers","year":"2011","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/bs.pbr.2019.03.001_bb0395","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.jconrel.2010.11.033","article-title":"Neurotherapeutic applications of nanoparticles in Alzheimer's disease","volume":"152","author":"Sahni","year":"2011","journal-title":"J. Control. Release"},{"key":"10.1016\/bs.pbr.2019.03.001_bb0400","first-page":"1749","article-title":"Liposomes functionalized to overcome the blood-brain barrier and to target amyloid-beta peptide: the chemical design affects the permeability across an in vitro model","volume":"8","author":"Salvati","year":"2013","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/bs.pbr.2019.03.001_bb0405","doi-asserted-by":"crossref","first-page":"3510","DOI":"10.1073\/pnas.1112209109","article-title":"Withania somnifera reverses Alzheimer's disease pathology by enhancing low-density lipoprotein receptor-related protein in liver","volume":"109","author":"Sehgal","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/bs.pbr.2019.03.001_bb0410","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S0925-4439(00)00029-6","article-title":"Alzheimer's amyloid fibrils: structure and assembly","volume":"1502","author":"Serpell","year":"2000","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/bs.pbr.2019.03.001_bb0415","first-page":"315","article-title":"Can estrogen keep you smart? Evidence from clinical studies","volume":"24","author":"Sherwin","year":"1999","journal-title":"J. Psychiatry Neurosci."},{"key":"10.1016\/bs.pbr.2019.03.001_bb0420","doi-asserted-by":"crossref","first-page":"S131","DOI":"10.1016\/j.jalz.2007.10.009","article-title":"More than a decade of estrogen neuroprotection","volume":"4","author":"Simpkins","year":"2008","journal-title":"Alzheimers Dement."},{"key":"10.1016\/bs.pbr.2019.03.001_bb0425","first-page":"4063","article-title":"Antibody-conjugated, dual-modal, near-infrared fluorescent iron oxide nanoparticles for antiamyloidgenic activity and specific detection of amyloid-\u03b2 fibrils","volume":"8","author":"Skaat","year":"2013","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/bs.pbr.2019.03.001_bb0430","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.conb.2014.02.003","article-title":"Beyond pathology: APP, brain development and Alzheimer's disease","volume":"27","author":"Soldano","year":"2014","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/bs.pbr.2019.03.001_bb0435","doi-asserted-by":"crossref","first-page":"3976","DOI":"10.1021\/acs.molpharmaceut.6b00781","article-title":"Biomimetic ApoE-reconstituted high density lipoprotein nanocarrier for blood-brain barrier penetration and amyloid Beta-targeting drug delivery","volume":"13","author":"Song","year":"2016","journal-title":"Mol. Pharm."},{"key":"10.1016\/bs.pbr.2019.03.001_bb0440","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1006\/bbrc.1996.1413","article-title":"Inhibition of Alzheimer's amyloidosis by peptides that prevent beta-sheet conformation","volume":"226","author":"Soto","year":"1996","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/bs.pbr.2019.03.001_bb0445","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1021\/acschemneuro.7b00312","article-title":"Sulfur nanoparticles with novel morphologies coupled with brain-targeting peptides RVG as a new type of inhibitor against metal-induced Abeta aggregation","volume":"9","author":"Sun","year":"2018","journal-title":"ACS Chem. Nerosci."},{"key":"10.1016\/bs.pbr.2019.03.001_bb0450","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.bbamcr.2009.04.003","article-title":"Matrix metalloproteinases: fold and function of their catalytic domains","volume":"1803","author":"Tallant","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/bs.pbr.2019.03.001_bb0455","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ijpharm.2016.10.031","article-title":"Nanomedicine as a non-invasive strategy for drug delivery across the blood brain barrier","volume":"515","author":"Tam","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/bs.pbr.2019.03.001_bb0460","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.nano.2011.06.015","article-title":"Effect of curcumin-associated and lipid ligand-functionalized nanoliposomes on aggregation of the Alzheimer's Abeta peptide","volume":"7","author":"Taylor","year":"2011","journal-title":"Nanomedicine"},{"key":"10.1016\/bs.pbr.2019.03.001_bb0465","doi-asserted-by":"crossref","first-page":"8545","DOI":"10.1074\/jbc.271.15.8545","article-title":"Arrest of beta-amyloid fibril formation by a pentapeptide ligand","volume":"271","author":"Tjernberg","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/bs.pbr.2019.03.001_bb0470","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2007.05.022","article-title":"Targeting the central nervous system: in vivo experiments with peptide-derivatized nanoparticles loaded with Loperamide and Rhodamine-123","volume":"122","author":"Tosi","year":"2007","journal-title":"J. Control. Release"},{"key":"10.1016\/bs.pbr.2019.03.001_bb0475","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1517\/17425247.5.2.155","article-title":"Polymeric nanoparticles for the drug delivery to the central nervous system","volume":"5","author":"Tosi","year":"2008","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/bs.pbr.2019.03.001_bb0480","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1166\/ajnn.2011.1032","article-title":"Nanoparticles for brain delivery of drugs: in vivo experiments and mechanism of blood-brain barrier crossing","volume":"3","author":"Tosi","year":"2011","journal-title":"Am. J. Neuroprot. Neuroregener."},{"key":"10.1016\/bs.pbr.2019.03.001_bb0485","doi-asserted-by":"crossref","first-page":"423","DOI":"10.2217\/nnm.11.11","article-title":"Investigation on mechanisms of glycopeptide nanoparticles for drug delivery across the blood\u2013brain barrier","volume":"6","author":"Tosi","year":"2011","journal-title":"Nanomedicine"},{"key":"10.1016\/bs.pbr.2019.03.001_bb0490","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.2174\/0929867311320170006","article-title":"Potential use of polymeric nanoparticles for drug delivery across the blood-brain barrier","volume":"20","author":"Tosi","year":"2013","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/bs.pbr.2019.03.001_bb0495","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.jtemb.2017.12.006","article-title":"Reduced plaque size and inflammation in the APP23 mouse model for Alzheimer's disease after chronic application of polymeric nanoparticles for CNS targeted zinc delivery","volume":"49","author":"Vilella","year":"2018","journal-title":"J. Trace Elem. Med. Biol."},{"key":"10.1016\/bs.pbr.2019.03.001_bb0500","doi-asserted-by":"crossref","first-page":"9752","DOI":"10.1039\/C4NR01005A","article-title":"The molecular mechanism of fullerene-inhibited aggregation of Alzheimer's beta-amyloid peptide fragment","volume":"6","author":"Xie","year":"2014","journal-title":"Nanoscale"},{"key":"10.1016\/bs.pbr.2019.03.001_bb0505","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.actbio.2015.06.035","article-title":"Sialic acid (SA)-modified selenium nanoparticles coated with a high blood-brain barrier permeability peptide-B6 peptide for potential use in Alzheimer's disease","volume":"25","author":"Yin","year":"2015","journal-title":"Acta Biomater."},{"key":"10.1016\/bs.pbr.2019.03.001_bb0510","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.biomaterials.2013.09.063","article-title":"Dual-functional nanoparticles targeting amyloid plaques in the brains of Alzheimer's disease mice","volume":"35","author":"Zhang","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/bs.pbr.2019.03.001_bb0515","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.jconrel.2014.07.050","article-title":"The potential use of H102 peptide-loaded dual-functional nanoparticles in the treatment of Alzheimer's disease","volume":"192","author":"Zhang","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/bs.pbr.2019.03.001_bb0520","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.actbio.2016.11.029","article-title":"A hybrid siRNA delivery complex for enhanced brain penetration and precise amyloid plaque targeting in Alzheimer's disease mice","volume":"49","author":"Zheng","year":"2017","journal-title":"Acta Biomater."},{"key":"10.1016\/bs.pbr.2019.03.001_bb0525","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.ijpharm.2017.04.033","article-title":"Dual-functional nanoparticles for precise drug delivery to Alzheimer's disease lesions: targeting mechanisms, pharmacodynamics and safety","volume":"525","author":"Zheng","year":"2017","journal-title":"Int. J. Pharm."}],"container-title":["Progress in Brain Research","Nanoneuroprotection and Nanoneurotoxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0079612319300317?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0079612319300317?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T12:57:02Z","timestamp":1786107422000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0079612319300317"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"ISBN":["9780444642080"],"references-count":104,"URL":"https:\/\/doi.org\/10.1016\/bs.pbr.2019.03.001","relation":{},"ISSN":["0079-6123"],"issn-type":[{"value":"0079-6123","type":"print"}],"subject":[],"published":{"date-parts":[[2019]]}}}